nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—TUBB2A—hematologic cancer	0.209	0.729	CbGaD
Cabazitaxel—ABCG2—hematologic cancer	0.0546	0.191	CbGaD
Cabazitaxel—TUBA4A—Vincristine—hematologic cancer	0.024	0.0505	CbGbCtD
Cabazitaxel—ABCB1—hematologic cancer	0.0227	0.0795	CbGaD
Cabazitaxel—TUBB6—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB8—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB2A—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB2B—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB4A—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB3—Vinorelbine—hematologic cancer	0.018	0.0381	CbGbCtD
Cabazitaxel—TUBB—Vinorelbine—hematologic cancer	0.0151	0.0318	CbGbCtD
Cabazitaxel—TUBB1—Vinorelbine—hematologic cancer	0.0151	0.0318	CbGbCtD
Cabazitaxel—TUBB4B—Vinorelbine—hematologic cancer	0.0151	0.0318	CbGbCtD
Cabazitaxel—TUBB8—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB2B—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB2A—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB4A—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB3—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB6—Vinblastine—hematologic cancer	0.0111	0.0235	CbGbCtD
Cabazitaxel—TUBB6—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB8—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB2B—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB4A—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB3—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB2A—Vincristine—hematologic cancer	0.0109	0.0231	CbGbCtD
Cabazitaxel—TUBB1—Vinblastine—hematologic cancer	0.0093	0.0196	CbGbCtD
Cabazitaxel—TUBB4B—Vinblastine—hematologic cancer	0.0093	0.0196	CbGbCtD
Cabazitaxel—TUBB—Vinblastine—hematologic cancer	0.0093	0.0196	CbGbCtD
Cabazitaxel—TUBB1—Vincristine—hematologic cancer	0.00914	0.0193	CbGbCtD
Cabazitaxel—TUBB—Vincristine—hematologic cancer	0.00914	0.0193	CbGbCtD
Cabazitaxel—TUBB4B—Vincristine—hematologic cancer	0.00914	0.0193	CbGbCtD
Cabazitaxel—ABCG2—Clofarabine—hematologic cancer	0.00736	0.0155	CbGbCtD
Cabazitaxel—ABCG2—Daunorubicin—hematologic cancer	0.00432	0.00911	CbGbCtD
Cabazitaxel—ABCG2—Teniposide—hematologic cancer	0.00375	0.00791	CbGbCtD
Cabazitaxel—ABCG2—Cladribine—hematologic cancer	0.0036	0.00758	CbGbCtD
Cabazitaxel—ABCG2—Imatinib—hematologic cancer	0.00331	0.00697	CbGbCtD
Cabazitaxel—ABCG2—Nilotinib—hematologic cancer	0.003	0.00634	CbGbCtD
Cabazitaxel—ABCG2—Dasatinib—hematologic cancer	0.00266	0.0056	CbGbCtD
Cabazitaxel—ABCB1—Lenalidomide—hematologic cancer	0.00265	0.0056	CbGbCtD
Cabazitaxel—ABCG2—Mitoxantrone—hematologic cancer	0.00262	0.00553	CbGbCtD
Cabazitaxel—SLCO1B1—Irinotecan—hematologic cancer	0.0026	0.00548	CbGbCtD
Cabazitaxel—CYP2C8—Bortezomib—hematologic cancer	0.0024	0.00507	CbGbCtD
Cabazitaxel—CYP3A5—Daunorubicin—hematologic cancer	0.00239	0.00504	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—hematologic cancer	0.00236	0.00498	CbGbCtD
Cabazitaxel—CYP3A5—Thalidomide—hematologic cancer	0.00218	0.00459	CbGbCtD
Cabazitaxel—CYP3A5—Teniposide—hematologic cancer	0.00208	0.00438	CbGbCtD
Cabazitaxel—ABCG2—Irinotecan—hematologic cancer	0.00207	0.00436	CbGbCtD
Cabazitaxel—CYP3A5—Ifosfamide—hematologic cancer	0.00192	0.00404	CbGbCtD
Cabazitaxel—CYP2C8—Ifosfamide—hematologic cancer	0.00184	0.00389	CbGbCtD
Cabazitaxel—CYP3A5—Imatinib—hematologic cancer	0.00183	0.00386	CbGbCtD
Cabazitaxel—ABCG2—Vincristine—hematologic cancer	0.00181	0.00381	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—hematologic cancer	0.00168	0.00355	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—hematologic cancer	0.00165	0.00349	CbGbCtD
Cabazitaxel—CYP2C8—Nilotinib—hematologic cancer	0.0016	0.00338	CbGbCtD
Cabazitaxel—CYP3A4—Bexarotene—hematologic cancer	0.00159	0.00336	CbGbCtD
Cabazitaxel—ABCB1—Daunorubicin—hematologic cancer	0.00156	0.00328	CbGbCtD
Cabazitaxel—ABCB1—Alitretinoin—hematologic cancer	0.00152	0.00322	CbGbCtD
Cabazitaxel—CYP3A4—Lomustine—hematologic cancer	0.00148	0.00312	CbGbCtD
Cabazitaxel—CYP3A4—Busulfan—hematologic cancer	0.00148	0.00312	CbGbCtD
Cabazitaxel—CYP3A5—Dasatinib—hematologic cancer	0.00147	0.0031	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—hematologic cancer	0.00138	0.0029	CbGbCtD
Cabazitaxel—ABCG2—Dexamethasone—hematologic cancer	0.00136	0.00287	CbGbCtD
Cabazitaxel—CYP3A4—Thiotepa—hematologic cancer	0.00132	0.00278	CbGbCtD
Cabazitaxel—TUBB3—hematopoietic system—hematologic cancer	0.00127	0.038	CbGeAlD
Cabazitaxel—TUBB1—hematopoietic system—hematologic cancer	0.00124	0.0372	CbGeAlD
Cabazitaxel—ABCB1—Imatinib—hematologic cancer	0.00119	0.00251	CbGbCtD
Cabazitaxel—CYP3A5—Irinotecan—hematologic cancer	0.00114	0.00241	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—hematologic cancer	0.00113	0.00238	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—hematologic cancer	0.00109	0.00231	CbGbCtD
Cabazitaxel—ABCB1—Nilotinib—hematologic cancer	0.00108	0.00229	CbGbCtD
Cabazitaxel—ABCB1—Vinorelbine—hematologic cancer	0.00107	0.00227	CbGbCtD
Cabazitaxel—CYP3A4—Methoxsalen—hematologic cancer	0.00102	0.00216	CbGbCtD
Cabazitaxel—TUBB8—testis—hematologic cancer	0.00102	0.0305	CbGeAlD
Cabazitaxel—CYP3A5—Vincristine—hematologic cancer	0.001	0.00211	CbGbCtD
Cabazitaxel—CYP3A4—Bortezomib—hematologic cancer	0.000975	0.00206	CbGbCtD
Cabazitaxel—TUBA4A—hematopoietic system—hematologic cancer	0.000966	0.0289	CbGeAlD
Cabazitaxel—ABCB1—Dasatinib—hematologic cancer	0.000957	0.00202	CbGbCtD
Cabazitaxel—ABCB1—Mitoxantrone—hematologic cancer	0.000946	0.002	CbGbCtD
Cabazitaxel—CYP3A4—Daunorubicin—hematologic cancer	0.000932	0.00197	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—hematologic cancer	0.000916	0.00193	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—hematologic cancer	0.000881	0.00186	CbGbCtD
Cabazitaxel—ABCB1—Betamethasone—hematologic cancer	0.000843	0.00178	CbGbCtD
Cabazitaxel—TUBB3—blood—hematologic cancer	0.000843	0.0252	CbGeAlD
Cabazitaxel—ABCB1—Gemcitabine—hematologic cancer	0.000835	0.00176	CbGbCtD
Cabazitaxel—ABCB1—Prednisolone—hematologic cancer	0.000832	0.00175	CbGbCtD
Cabazitaxel—TUBB1—blood—hematologic cancer	0.000824	0.0246	CbGeAlD
Cabazitaxel—CYP3A4—Cytarabine—hematologic cancer	0.000823	0.00174	CbGbCtD
Cabazitaxel—CYP3A4—Teniposide—hematologic cancer	0.00081	0.00171	CbGbCtD
Cabazitaxel—TUBB1—bone marrow—hematologic cancer	0.000797	0.0238	CbGeAlD
Cabazitaxel—ABCB1—Prednisone—hematologic cancer	0.000785	0.00166	CbGbCtD
Cabazitaxel—TUBB4A—hematopoietic system—hematologic cancer	0.000774	0.0231	CbGeAlD
Cabazitaxel—CYP3A5—Dexamethasone—hematologic cancer	0.000753	0.00159	CbGbCtD
Cabazitaxel—Docetaxel—TUBB2A—hematologic cancer	0.000752	0.261	CrCbGaD
Cabazitaxel—Paclitaxel—TUBB2A—hematologic cancer	0.000752	0.261	CrCbGaD
Cabazitaxel—CYP3A4—Ifosfamide—hematologic cancer	0.000748	0.00158	CbGbCtD
Cabazitaxel—ABCB1—Irinotecan—hematologic cancer	0.000745	0.00157	CbGbCtD
Cabazitaxel—TUBB3—lung—hematologic cancer	0.000739	0.0221	CbGeAlD
Cabazitaxel—TUBA4A—gonad—hematologic cancer	0.000734	0.0219	CbGeAlD
Cabazitaxel—CYP2C8—Dexamethasone—hematologic cancer	0.000724	0.00153	CbGbCtD
Cabazitaxel—CYP3A4—Imatinib—hematologic cancer	0.000714	0.00151	CbGbCtD
Cabazitaxel—TUBB2A—hematopoietic system—hematologic cancer	0.000704	0.021	CbGeAlD
Cabazitaxel—TUBB3—testis—hematologic cancer	0.000697	0.0208	CbGeAlD
Cabazitaxel—TUBB6—hematopoietic system—hematologic cancer	0.000694	0.0207	CbGeAlD
Cabazitaxel—TUBB1—testis—hematologic cancer	0.000681	0.0204	CbGeAlD
Cabazitaxel—CYP3A4—Ruxolitinib—hematologic cancer	0.000673	0.00142	CbGbCtD
Cabazitaxel—ABCB1—Vinblastine—hematologic cancer	0.000662	0.0014	CbGbCtD
Cabazitaxel—ABCB1—Vincristine—hematologic cancer	0.000651	0.00137	CbGbCtD
Cabazitaxel—CYP3A4—Nilotinib—hematologic cancer	0.000649	0.00137	CbGbCtD
Cabazitaxel—SLCO1B3—lung—hematologic cancer	0.000647	0.0193	CbGeAlD
Cabazitaxel—SLCO1B1—hematopoietic system—hematologic cancer	0.000644	0.0192	CbGeAlD
Cabazitaxel—CYP3A4—Vinorelbine—hematologic cancer	0.000644	0.00136	CbGbCtD
Cabazitaxel—TUBA4A—blood—hematologic cancer	0.00064	0.0191	CbGeAlD
Cabazitaxel—TUBA4A—bone marrow—hematologic cancer	0.000619	0.0185	CbGeAlD
Cabazitaxel—ABCB1—Cisplatin—hematologic cancer	0.000607	0.00128	CbGbCtD
Cabazitaxel—TUBB4B—hematopoietic system—hematologic cancer	0.000604	0.018	CbGeAlD
Cabazitaxel—ABCB1—Etoposide—hematologic cancer	0.000596	0.00126	CbGbCtD
Cabazitaxel—CYP3A4—Triamcinolone—hematologic cancer	0.000589	0.00124	CbGbCtD
Cabazitaxel—TUBB4A—gonad—hematologic cancer	0.000588	0.0176	CbGeAlD
Cabazitaxel—CYP3A4—Dasatinib—hematologic cancer	0.000574	0.00121	CbGbCtD
Cabazitaxel—TUBB2B—gonad—hematologic cancer	0.000569	0.017	CbGeAlD
Cabazitaxel—CYP3A4—Mitoxantrone—hematologic cancer	0.000567	0.0012	CbGbCtD
Cabazitaxel—TUBA4A—lung—hematologic cancer	0.000561	0.0168	CbGeAlD
Cabazitaxel—TUBA4A—testis—hematologic cancer	0.000529	0.0158	CbGeAlD
Cabazitaxel—TUBB6—gonad—hematologic cancer	0.000528	0.0158	CbGeAlD
Cabazitaxel—TUBB4A—blood—hematologic cancer	0.000513	0.0153	CbGeAlD
Cabazitaxel—CYP3A4—Betamethasone—hematologic cancer	0.000505	0.00107	CbGbCtD
Cabazitaxel—CYP3A4—Prednisolone—hematologic cancer	0.000498	0.00105	CbGbCtD
Cabazitaxel—ABCB1—Dexamethasone—hematologic cancer	0.00049	0.00103	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—hematologic cancer	0.000471	0.000993	CbGbCtD
Cabazitaxel—TUBB—blood—hematologic cancer	0.000469	0.014	CbGeAlD
Cabazitaxel—TUBB2A—blood—hematologic cancer	0.000466	0.0139	CbGeAlD
Cabazitaxel—TUBB6—blood—hematologic cancer	0.00046	0.0137	CbGeAlD
Cabazitaxel—TUBB4B—gonad—hematologic cancer	0.000459	0.0137	CbGeAlD
Cabazitaxel—TUBB—bone marrow—hematologic cancer	0.000454	0.0136	CbGeAlD
Cabazitaxel—TUBB2A—bone marrow—hematologic cancer	0.000451	0.0135	CbGeAlD
Cabazitaxel—TUBB4A—lung—hematologic cancer	0.000449	0.0134	CbGeAlD
Cabazitaxel—CYP3A4—Irinotecan—hematologic cancer	0.000446	0.000941	CbGbCtD
Cabazitaxel—TUBB6—bone marrow—hematologic cancer	0.000445	0.0133	CbGeAlD
Cabazitaxel—TUBB2B—lung—hematologic cancer	0.000434	0.013	CbGeAlD
Cabazitaxel—SLCO1B1—blood—hematologic cancer	0.000427	0.0127	CbGeAlD
Cabazitaxel—TUBB4A—testis—hematologic cancer	0.000424	0.0127	CbGeAlD
Cabazitaxel—Paclitaxel—BCL2—hematologic cancer	0.000412	0.143	CrCbGaD
Cabazitaxel—Docetaxel—BCL2—hematologic cancer	0.000412	0.143	CrCbGaD
Cabazitaxel—TUBB—lung—hematologic cancer	0.000411	0.0123	CbGeAlD
Cabazitaxel—TUBB2B—testis—hematologic cancer	0.00041	0.0122	CbGeAlD
Cabazitaxel—TUBB2A—lung—hematologic cancer	0.000409	0.0122	CbGeAlD
Cabazitaxel—ABCB1—Doxorubicin—hematologic cancer	0.000407	0.000858	CbGbCtD
Cabazitaxel—TUBB6—lung—hematologic cancer	0.000403	0.0121	CbGeAlD
Cabazitaxel—TUBB4B—blood—hematologic cancer	0.0004	0.0119	CbGeAlD
Cabazitaxel—CYP3A4—Vinblastine—hematologic cancer	0.000397	0.000837	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—hematologic cancer	0.000394	0.000831	CbGbCtD
Cabazitaxel—CYP3A4—Vincristine—hematologic cancer	0.00039	0.000823	CbGbCtD
Cabazitaxel—TUBB—testis—hematologic cancer	0.000388	0.0116	CbGeAlD
Cabazitaxel—TUBB4B—bone marrow—hematologic cancer	0.000387	0.0116	CbGeAlD
Cabazitaxel—TUBB2A—testis—hematologic cancer	0.000386	0.0115	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—hematologic cancer	0.000384	0.0115	CbGeAlD
Cabazitaxel—TUBB6—testis—hematologic cancer	0.000381	0.0114	CbGeAlD
Cabazitaxel—CYP2C8—hematopoietic system—hematologic cancer	0.000366	0.0109	CbGeAlD
Cabazitaxel—CYP3A4—Etoposide—hematologic cancer	0.000357	0.000754	CbGbCtD
Cabazitaxel—TUBB4B—lung—hematologic cancer	0.000351	0.0105	CbGeAlD
Cabazitaxel—TUBB4B—testis—hematologic cancer	0.000331	0.00988	CbGeAlD
Cabazitaxel—CYP3A5—hematopoietic system—hematologic cancer	0.00033	0.00987	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—hematologic cancer	0.000307	0.00919	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—hematologic cancer	0.000297	0.00888	CbGeAlD
Cabazitaxel—CYP3A4—Dexamethasone—hematologic cancer	0.000294	0.00062	CbGbCtD
Cabazitaxel—TUBB—lymph node—hematologic cancer	0.000281	0.0084	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—hematologic cancer	0.00028	0.00836	CbGeAlD
Cabazitaxel—TUBB6—lymph node—hematologic cancer	0.000276	0.00824	CbGeAlD
Cabazitaxel—CYP3A4—hematopoietic system—hematologic cancer	0.000248	0.00741	CbGeAlD
Cabazitaxel—CYP3A4—Doxorubicin—hematologic cancer	0.000244	0.000514	CbGbCtD
Cabazitaxel—CYP2C8—blood—hematologic cancer	0.000243	0.00725	CbGeAlD
Cabazitaxel—TUBB—Menadione—Thalidomide—hematologic cancer	0.000241	0.127	CbGdCrCtD
Cabazitaxel—TUBB4B—lymph node—hematologic cancer	0.00024	0.00716	CbGeAlD
Cabazitaxel—ABCG2—blood—hematologic cancer	0.000236	0.00705	CbGeAlD
Cabazitaxel—ABCG2—bone marrow—hematologic cancer	0.000228	0.00682	CbGeAlD
Cabazitaxel—CYP3A5—blood—hematologic cancer	0.000219	0.00654	CbGeAlD
Cabazitaxel—ABCG2—lung—hematologic cancer	0.000207	0.00618	CbGeAlD
Cabazitaxel—CYP2C8—testis—hematologic cancer	0.000201	0.006	CbGeAlD
Cabazitaxel—Paclitaxel—ABCG2—hematologic cancer	0.000197	0.0682	CrCbGaD
Cabazitaxel—Docetaxel—ABCG2—hematologic cancer	0.000197	0.0682	CrCbGaD
Cabazitaxel—ABCG2—testis—hematologic cancer	0.000195	0.00583	CbGeAlD
Cabazitaxel—CYP3A5—lung—hematologic cancer	0.000192	0.00574	CbGeAlD
Cabazitaxel—TUBB6—Vitamin A—Alitretinoin—hematologic cancer	0.000189	0.0991	CbGdCrCtD
Cabazitaxel—ABCB1—hematopoietic system—hematologic cancer	0.000176	0.00525	CbGeAlD
Cabazitaxel—CYP3A4—blood—hematologic cancer	0.000164	0.00491	CbGeAlD
Cabazitaxel—TUBB6—Zalcitabine—Cytarabine—hematologic cancer	0.00015	0.0787	CbGdCrCtD
Cabazitaxel—TUBB6—Zalcitabine—Gemcitabine—hematologic cancer	0.00015	0.0787	CbGdCrCtD
Cabazitaxel—ABCG2—lymph node—hematologic cancer	0.000141	0.00423	CbGeAlD
Cabazitaxel—ABCB1—gonad—hematologic cancer	0.000133	0.00399	CbGeAlD
Cabazitaxel—TUBB6—Tretinoin—Alitretinoin—hematologic cancer	0.000132	0.0692	CbGdCrCtD
Cabazitaxel—TUBB6—Isotretinoin—Alitretinoin—hematologic cancer	0.000132	0.0692	CbGdCrCtD
Cabazitaxel—TUBB—Azacitidine—Pentostatin—hematologic cancer	0.000123	0.0649	CbGdCrCtD
Cabazitaxel—ABCB1—blood—hematologic cancer	0.000116	0.00348	CbGeAlD
Cabazitaxel—ABCB1—bone marrow—hematologic cancer	0.000113	0.00336	CbGeAlD
Cabazitaxel—TUBB—Azacitidine—Clofarabine—hematologic cancer	0.00011	0.0578	CbGdCrCtD
Cabazitaxel—TUBB—Azacitidine—Nelarabine—hematologic cancer	0.000103	0.0544	CbGdCrCtD
Cabazitaxel—ABCB1—lung—hematologic cancer	0.000102	0.00305	CbGeAlD
Cabazitaxel—ABCB1—testis—hematologic cancer	9.62e-05	0.00287	CbGeAlD
Cabazitaxel—Paclitaxel—ABCB1—hematologic cancer	8.2e-05	0.0284	CrCbGaD
Cabazitaxel—Docetaxel—ABCB1—hematologic cancer	8.2e-05	0.0284	CrCbGaD
Cabazitaxel—TUBB—Azacitidine—Fludarabine—hematologic cancer	8.07e-05	0.0424	CbGdCrCtD
Cabazitaxel—TUBB—Azacitidine—Gemcitabine—hematologic cancer	7.63e-05	0.0401	CbGdCrCtD
Cabazitaxel—TUBB—Azacitidine—Cytarabine—hematologic cancer	7.63e-05	0.0401	CbGdCrCtD
Cabazitaxel—TUBB—Azacitidine—Cladribine—hematologic cancer	7.43e-05	0.039	CbGdCrCtD
Cabazitaxel—ABCB1—lymph node—hematologic cancer	6.97e-05	0.00208	CbGeAlD
Cabazitaxel—TUBB6—Azacitidine—Pentostatin—hematologic cancer	5.1e-05	0.0268	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Clofarabine—hematologic cancer	4.54e-05	0.0239	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Nelarabine—hematologic cancer	4.27e-05	0.0224	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Fludarabine—hematologic cancer	3.34e-05	0.0175	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Gemcitabine—hematologic cancer	3.15e-05	0.0166	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Cytarabine—hematologic cancer	3.15e-05	0.0166	CbGdCrCtD
Cabazitaxel—TUBB6—Azacitidine—Cladribine—hematologic cancer	3.07e-05	0.0161	CbGdCrCtD
Cabazitaxel—Anxiety—Prednisone—hematologic cancer	1.28e-05	9.57e-05	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—hematologic cancer	1.28e-05	9.57e-05	CcSEcCtD
Cabazitaxel—Vomiting—Gemcitabine—hematologic cancer	1.28e-05	9.57e-05	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.28e-05	9.54e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Dexamethasone—hematologic cancer	1.27e-05	9.49e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Betamethasone—hematologic cancer	1.27e-05	9.49e-05	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—hematologic cancer	1.27e-05	9.49e-05	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—hematologic cancer	1.27e-05	9.49e-05	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—hematologic cancer	1.27e-05	9.47e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—hematologic cancer	1.27e-05	9.47e-05	CcSEcCtD
Cabazitaxel—Tinnitus—Epirubicin—hematologic cancer	1.27e-05	9.45e-05	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—hematologic cancer	1.26e-05	9.43e-05	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—hematologic cancer	1.26e-05	9.43e-05	CcSEcCtD
Cabazitaxel—Headache—Gemcitabine—hematologic cancer	1.26e-05	9.43e-05	CcSEcCtD
Cabazitaxel—Nausea—Vincristine—hematologic cancer	1.26e-05	9.42e-05	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—hematologic cancer	1.26e-05	9.41e-05	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—hematologic cancer	1.26e-05	9.41e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisolone—hematologic cancer	1.25e-05	9.34e-05	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—hematologic cancer	1.25e-05	9.33e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Dexamethasone—hematologic cancer	1.25e-05	9.31e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Betamethasone—hematologic cancer	1.25e-05	9.31e-05	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—hematologic cancer	1.24e-05	9.26e-05	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—hematologic cancer	1.24e-05	9.24e-05	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—hematologic cancer	1.24e-05	9.23e-05	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—hematologic cancer	1.24e-05	9.22e-05	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—hematologic cancer	1.24e-05	9.22e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Triamcinolone—hematologic cancer	1.24e-05	9.21e-05	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—hematologic cancer	1.23e-05	9.21e-05	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—hematologic cancer	1.23e-05	9.2e-05	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—hematologic cancer	1.23e-05	9.19e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Betamethasone—hematologic cancer	1.23e-05	9.19e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Dexamethasone—hematologic cancer	1.23e-05	9.19e-05	CcSEcCtD
Cabazitaxel—Nausea—Mitoxantrone—hematologic cancer	1.23e-05	9.17e-05	CcSEcCtD
Cabazitaxel—Nausea—Irinotecan—hematologic cancer	1.23e-05	9.17e-05	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—hematologic cancer	1.23e-05	9.16e-05	CcSEcCtD
Cabazitaxel—Infection—Prednisone—hematologic cancer	1.23e-05	9.15e-05	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—hematologic cancer	1.23e-05	9.14e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.22e-05	9.13e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.22e-05	9.13e-05	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—hematologic cancer	1.22e-05	9.12e-05	CcSEcCtD
Cabazitaxel—Fatigue—Dexamethasone—hematologic cancer	1.22e-05	9.12e-05	CcSEcCtD
Cabazitaxel—Fatigue—Betamethasone—hematologic cancer	1.22e-05	9.12e-05	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—hematologic cancer	1.22e-05	9.1e-05	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—hematologic cancer	1.21e-05	9.06e-05	CcSEcCtD
Cabazitaxel—Pain—Betamethasone—hematologic cancer	1.21e-05	9.04e-05	CcSEcCtD
Cabazitaxel—Pain—Dexamethasone—hematologic cancer	1.21e-05	9.04e-05	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—hematologic cancer	1.21e-05	9.03e-05	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—hematologic cancer	1.21e-05	8.99e-05	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—hematologic cancer	1.2e-05	8.96e-05	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—hematologic cancer	1.2e-05	8.94e-05	CcSEcCtD
Cabazitaxel—Nausea—Gemcitabine—hematologic cancer	1.2e-05	8.94e-05	CcSEcCtD
Cabazitaxel—Vomiting—Cisplatin—hematologic cancer	1.2e-05	8.92e-05	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—hematologic cancer	1.19e-05	8.88e-05	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—hematologic cancer	1.18e-05	8.82e-05	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—hematologic cancer	1.18e-05	8.82e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—hematologic cancer	1.18e-05	8.79e-05	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—hematologic cancer	1.18e-05	8.78e-05	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—hematologic cancer	1.18e-05	8.77e-05	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—hematologic cancer	1.17e-05	8.75e-05	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—hematologic cancer	1.17e-05	8.75e-05	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—hematologic cancer	1.17e-05	8.72e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Dexamethasone—hematologic cancer	1.17e-05	8.71e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Betamethasone—hematologic cancer	1.17e-05	8.71e-05	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—hematologic cancer	1.17e-05	8.7e-05	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—hematologic cancer	1.17e-05	8.7e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Betamethasone—hematologic cancer	1.16e-05	8.65e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.16e-05	8.65e-05	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—hematologic cancer	1.16e-05	8.64e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Triamcinolone—hematologic cancer	1.15e-05	8.59e-05	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—hematologic cancer	1.14e-05	8.54e-05	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—hematologic cancer	1.14e-05	8.51e-05	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—hematologic cancer	1.14e-05	8.5e-05	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—hematologic cancer	1.14e-05	8.5e-05	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—hematologic cancer	1.14e-05	8.48e-05	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—hematologic cancer	1.14e-05	8.47e-05	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—hematologic cancer	1.14e-05	8.47e-05	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—hematologic cancer	1.13e-05	8.45e-05	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—hematologic cancer	1.13e-05	8.44e-05	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—hematologic cancer	1.13e-05	8.42e-05	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.13e-05	8.39e-05	CcSEcCtD
Cabazitaxel—Dizziness—Prednisolone—hematologic cancer	1.12e-05	8.38e-05	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—hematologic cancer	1.12e-05	8.38e-05	CcSEcCtD
Cabazitaxel—Asthenia—Triamcinolone—hematologic cancer	1.12e-05	8.36e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Dexamethasone—hematologic cancer	1.12e-05	8.36e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Dexamethasone—hematologic cancer	1.12e-05	8.36e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Betamethasone—hematologic cancer	1.12e-05	8.36e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Betamethasone—hematologic cancer	1.12e-05	8.36e-05	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—hematologic cancer	1.12e-05	8.33e-05	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—hematologic cancer	1.11e-05	8.29e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—hematologic cancer	1.11e-05	8.27e-05	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—hematologic cancer	1.1e-05	8.23e-05	CcSEcCtD
Cabazitaxel—Mental disorder—Doxorubicin—hematologic cancer	1.1e-05	8.22e-05	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—hematologic cancer	1.1e-05	8.19e-05	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—hematologic cancer	1.1e-05	8.17e-05	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—hematologic cancer	1.09e-05	8.16e-05	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—hematologic cancer	1.09e-05	8.16e-05	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—hematologic cancer	1.09e-05	8.16e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—hematologic cancer	1.09e-05	8.11e-05	CcSEcCtD
Cabazitaxel—Headache—Etoposide—hematologic cancer	1.08e-05	8.05e-05	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—hematologic cancer	1.08e-05	8.03e-05	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—hematologic cancer	1.08e-05	8.03e-05	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—hematologic cancer	1.08e-05	8.03e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—hematologic cancer	1.07e-05	8e-05	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—hematologic cancer	1.07e-05	8e-05	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.07e-05	7.97e-05	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—hematologic cancer	1.07e-05	7.96e-05	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—hematologic cancer	1.06e-05	7.94e-05	CcSEcCtD
Cabazitaxel—Headache—Prednisolone—hematologic cancer	1.06e-05	7.94e-05	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—hematologic cancer	1.06e-05	7.93e-05	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—hematologic cancer	1.06e-05	7.93e-05	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—hematologic cancer	1.06e-05	7.9e-05	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—hematologic cancer	1.06e-05	7.9e-05	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—hematologic cancer	1.06e-05	7.87e-05	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—hematologic cancer	1.05e-05	7.85e-05	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—hematologic cancer	1.04e-05	7.76e-05	CcSEcCtD
Cabazitaxel—Dizziness—Triamcinolone—hematologic cancer	1.03e-05	7.71e-05	CcSEcCtD
Cabazitaxel—Cough—Epirubicin—hematologic cancer	1.03e-05	7.7e-05	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—hematologic cancer	1.03e-05	7.65e-05	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—hematologic cancer	1.02e-05	7.63e-05	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—hematologic cancer	1.02e-05	7.62e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisone—hematologic cancer	1.02e-05	7.59e-05	CcSEcCtD
Cabazitaxel—Asthenia—Dexamethasone—hematologic cancer	1.02e-05	7.59e-05	CcSEcCtD
Cabazitaxel—Asthenia—Betamethasone—hematologic cancer	1.02e-05	7.59e-05	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—hematologic cancer	1.02e-05	7.58e-05	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—hematologic cancer	1.01e-05	7.55e-05	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—hematologic cancer	1.01e-05	7.55e-05	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—hematologic cancer	1.01e-05	7.53e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Prednisone—hematologic cancer	1.01e-05	7.53e-05	CcSEcCtD
Cabazitaxel—Nausea—Prednisolone—hematologic cancer	1.01e-05	7.53e-05	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—hematologic cancer	1.01e-05	7.51e-05	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—hematologic cancer	1.01e-05	7.51e-05	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—hematologic cancer	1.01e-05	7.51e-05	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—hematologic cancer	1e-05	7.49e-05	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—hematologic cancer	1e-05	7.48e-05	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1e-05	7.46e-05	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—hematologic cancer	9.95e-06	7.42e-05	CcSEcCtD
Cabazitaxel—Vomiting—Triamcinolone—hematologic cancer	9.94e-06	7.41e-05	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—hematologic cancer	9.87e-06	7.36e-05	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—hematologic cancer	9.85e-06	7.35e-05	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—hematologic cancer	9.84e-06	7.34e-05	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—hematologic cancer	9.84e-06	7.34e-05	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—hematologic cancer	9.8e-06	7.31e-05	CcSEcCtD
Cabazitaxel—Headache—Triamcinolone—hematologic cancer	9.79e-06	7.3e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—hematologic cancer	9.76e-06	7.28e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—hematologic cancer	9.76e-06	7.28e-05	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—hematologic cancer	9.74e-06	7.26e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Dexamethasone—hematologic cancer	9.7e-06	7.23e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Betamethasone—hematologic cancer	9.7e-06	7.23e-05	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—hematologic cancer	9.66e-06	7.2e-05	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—hematologic cancer	9.64e-06	7.19e-05	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—hematologic cancer	9.6e-06	7.15e-05	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—hematologic cancer	9.55e-06	7.12e-05	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—hematologic cancer	9.47e-06	7.06e-05	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—hematologic cancer	9.46e-06	7.05e-05	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—hematologic cancer	9.45e-06	7.05e-05	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—hematologic cancer	9.43e-06	7.03e-05	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—hematologic cancer	9.4e-06	7.01e-05	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—hematologic cancer	9.38e-06	7e-05	CcSEcCtD
Cabazitaxel—Dizziness—Dexamethasone—hematologic cancer	9.38e-06	6.99e-05	CcSEcCtD
Cabazitaxel—Dizziness—Betamethasone—hematologic cancer	9.38e-06	6.99e-05	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—hematologic cancer	9.32e-06	6.95e-05	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—hematologic cancer	9.32e-06	6.95e-05	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—hematologic cancer	9.32e-06	6.95e-05	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—hematologic cancer	9.29e-06	6.93e-05	CcSEcCtD
Cabazitaxel—Nausea—Triamcinolone—hematologic cancer	9.28e-06	6.92e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—hematologic cancer	9.27e-06	6.91e-05	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.26e-06	6.9e-05	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—hematologic cancer	9.21e-06	6.87e-05	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—hematologic cancer	9.21e-06	6.86e-05	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—hematologic cancer	9.2e-06	6.86e-05	CcSEcCtD
Cabazitaxel—Dry mouth—Doxorubicin—hematologic cancer	9.12e-06	6.8e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisone—hematologic cancer	9.1e-06	6.78e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—hematologic cancer	9.08e-06	6.77e-05	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—hematologic cancer	9.02e-06	6.73e-05	CcSEcCtD
Cabazitaxel—Vomiting—Dexamethasone—hematologic cancer	9.02e-06	6.72e-05	CcSEcCtD
Cabazitaxel—Vomiting—Betamethasone—hematologic cancer	9.02e-06	6.72e-05	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—hematologic cancer	9.01e-06	6.72e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—hematologic cancer	8.97e-06	6.69e-05	CcSEcCtD
Cabazitaxel—Oedema—Doxorubicin—hematologic cancer	8.94e-06	6.66e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.91e-06	6.64e-05	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—hematologic cancer	8.9e-06	6.63e-05	CcSEcCtD
Cabazitaxel—Headache—Dexamethasone—hematologic cancer	8.88e-06	6.62e-05	CcSEcCtD
Cabazitaxel—Headache—Betamethasone—hematologic cancer	8.88e-06	6.62e-05	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—hematologic cancer	8.88e-06	6.62e-05	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—hematologic cancer	8.86e-06	6.61e-05	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—hematologic cancer	8.83e-06	6.58e-05	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.8e-06	6.56e-05	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—hematologic cancer	8.76e-06	6.53e-05	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—hematologic cancer	8.75e-06	6.52e-05	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—hematologic cancer	8.72e-06	6.5e-05	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—hematologic cancer	8.68e-06	6.47e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—hematologic cancer	8.67e-06	6.47e-05	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—hematologic cancer	8.61e-06	6.42e-05	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—hematologic cancer	8.52e-06	6.35e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—hematologic cancer	8.5e-06	6.34e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—hematologic cancer	8.5e-06	6.34e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—hematologic cancer	8.45e-06	6.3e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—hematologic cancer	8.44e-06	6.29e-05	CcSEcCtD
Cabazitaxel—Nausea—Dexamethasone—hematologic cancer	8.42e-06	6.28e-05	CcSEcCtD
Cabazitaxel—Nausea—Betamethasone—hematologic cancer	8.42e-06	6.28e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—hematologic cancer	8.4e-06	6.26e-05	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—hematologic cancer	8.35e-06	6.23e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.34e-06	6.22e-05	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—hematologic cancer	8.33e-06	6.21e-05	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—hematologic cancer	8.26e-06	6.16e-05	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—hematologic cancer	8.26e-06	6.16e-05	CcSEcCtD
Cabazitaxel—Dizziness—Prednisone—hematologic cancer	8.17e-06	6.09e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—hematologic cancer	8.16e-06	6.08e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—hematologic cancer	8.16e-06	6.08e-05	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	8.14e-06	6.07e-05	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—hematologic cancer	8.02e-06	5.98e-05	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—hematologic cancer	7.97e-06	5.94e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—hematologic cancer	7.96e-06	5.93e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—hematologic cancer	7.9e-06	5.89e-05	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—hematologic cancer	7.87e-06	5.87e-05	CcSEcCtD
Cabazitaxel—Vomiting—Prednisone—hematologic cancer	7.85e-06	5.85e-05	CcSEcCtD
Cabazitaxel—Decreased appetite—Doxorubicin—hematologic cancer	7.77e-06	5.79e-05	CcSEcCtD
Cabazitaxel—Headache—Prednisone—hematologic cancer	7.74e-06	5.77e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.72e-06	5.75e-05	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—hematologic cancer	7.7e-06	5.75e-05	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—hematologic cancer	7.64e-06	5.7e-05	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—hematologic cancer	7.64e-06	5.7e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—hematologic cancer	7.63e-06	5.69e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—hematologic cancer	7.63e-06	5.69e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—hematologic cancer	7.6e-06	5.67e-05	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—hematologic cancer	7.4e-06	5.52e-05	CcSEcCtD
Cabazitaxel—Feeling abnormal—Doxorubicin—hematologic cancer	7.36e-06	5.49e-05	CcSEcCtD
Cabazitaxel—Nausea—Prednisone—hematologic cancer	7.34e-06	5.47e-05	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—hematologic cancer	7.31e-06	5.45e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Epirubicin—hematologic cancer	7.12e-06	5.31e-05	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—hematologic cancer	7.06e-06	5.27e-05	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—hematologic cancer	7.06e-06	5.27e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—hematologic cancer	7.06e-06	5.27e-05	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—hematologic cancer	6.93e-06	5.17e-05	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—hematologic cancer	6.82e-06	5.09e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Epirubicin—hematologic cancer	6.61e-06	4.93e-05	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—hematologic cancer	6.58e-06	4.91e-05	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—hematologic cancer	6.56e-06	4.89e-05	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—hematologic cancer	6.47e-06	4.82e-05	CcSEcCtD
Cabazitaxel—Asthenia—Doxorubicin—hematologic cancer	6.41e-06	4.78e-05	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—hematologic cancer	6.39e-06	4.76e-05	CcSEcCtD
Cabazitaxel—Vomiting—Epirubicin—hematologic cancer	6.14e-06	4.58e-05	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—hematologic cancer	6.13e-06	4.57e-05	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—hematologic cancer	6.11e-06	4.56e-05	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—hematologic cancer	6.05e-06	4.51e-05	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—hematologic cancer	5.91e-06	4.41e-05	CcSEcCtD
Cabazitaxel—Nausea—Epirubicin—hematologic cancer	5.74e-06	4.28e-05	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—hematologic cancer	5.68e-06	4.24e-05	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—hematologic cancer	5.6e-06	4.17e-05	CcSEcCtD
Cabazitaxel—Nausea—Doxorubicin—hematologic cancer	5.31e-06	3.96e-05	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism—CD44—hematologic cancer	2.92e-06	4.33e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NQO1—hematologic cancer	2.92e-06	4.33e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.9e-06	4.29e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.89e-06	4.28e-05	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—hematologic cancer	2.88e-06	4.27e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ARNTL—hematologic cancer	2.88e-06	4.27e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—FHL2—hematologic cancer	2.87e-06	4.25e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.86e-06	4.24e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.85e-06	4.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—UGT1A1—hematologic cancer	2.83e-06	4.19e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.82e-06	4.19e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AGRN—hematologic cancer	2.81e-06	4.17e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ACP5—hematologic cancer	2.8e-06	4.15e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CA9—hematologic cancer	2.8e-06	4.15e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOR2—hematologic cancer	2.76e-06	4.1e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYCS—hematologic cancer	2.76e-06	4.09e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CRABP1—hematologic cancer	2.75e-06	4.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC22A1—hematologic cancer	2.75e-06	4.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.75e-06	4.07e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HSP90AA1—hematologic cancer	2.74e-06	4.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CD44—hematologic cancer	2.7e-06	4.01e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NQO1—hematologic cancer	2.7e-06	4.01e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—DCK—hematologic cancer	2.69e-06	3.99e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.69e-06	3.99e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ASNS—hematologic cancer	2.69e-06	3.99e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALOX5—hematologic cancer	2.68e-06	3.97e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.67e-06	3.96e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—IDH2—hematologic cancer	2.67e-06	3.95e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HMMR—hematologic cancer	2.67e-06	3.95e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—IDH1—hematologic cancer	2.63e-06	3.9e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TXN—hematologic cancer	2.6e-06	3.86e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTO1—hematologic cancer	2.6e-06	3.86e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCC3—hematologic cancer	2.6e-06	3.86e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NUP98—hematologic cancer	2.59e-06	3.85e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.59e-06	3.84e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYCS—hematologic cancer	2.56e-06	3.79e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HDC—hematologic cancer	2.55e-06	3.78e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SPHK1—hematologic cancer	2.55e-06	3.78e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HSP90AA1—hematologic cancer	2.54e-06	3.77e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.53e-06	3.75e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ADCY7—hematologic cancer	2.52e-06	3.73e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOA3—hematologic cancer	2.52e-06	3.73e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ARNTL—hematologic cancer	2.51e-06	3.72e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NUP214—hematologic cancer	2.5e-06	3.71e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CG—hematologic cancer	2.47e-06	3.67e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.47e-06	3.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.46e-06	3.65e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.46e-06	3.64e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCG2—hematologic cancer	2.45e-06	3.63e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTR—hematologic cancer	2.45e-06	3.63e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—UGT1A1—hematologic cancer	2.45e-06	3.63e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ACP5—hematologic cancer	2.44e-06	3.62e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CA9—hematologic cancer	2.44e-06	3.62e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTP1—hematologic cancer	2.44e-06	3.61e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOR2—hematologic cancer	2.41e-06	3.57e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO2—hematologic cancer	2.4e-06	3.56e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC22A1—hematologic cancer	2.38e-06	3.53e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CRABP1—hematologic cancer	2.38e-06	3.53e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.36e-06	3.49e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CDA—hematologic cancer	2.33e-06	3.46e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTT1—hematologic cancer	2.33e-06	3.45e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALOX5—hematologic cancer	2.32e-06	3.44e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ABCB1—hematologic cancer	2.31e-06	3.42e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—IDH1—hematologic cancer	2.29e-06	3.4e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CREBBP—hematologic cancer	2.29e-06	3.4e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.29e-06	3.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SDC1—hematologic cancer	2.28e-06	3.38e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.27e-06	3.37e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ABCC3—hematologic cancer	2.27e-06	3.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TXN—hematologic cancer	2.27e-06	3.36e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTO1—hematologic cancer	2.27e-06	3.36e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTP1—hematologic cancer	2.25e-06	3.34e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NUP98—hematologic cancer	2.25e-06	3.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PC—hematologic cancer	2.25e-06	3.33e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NCOR1—hematologic cancer	2.24e-06	3.32e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GSTM1—hematologic cancer	2.24e-06	3.32e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SPHK1—hematologic cancer	2.22e-06	3.29e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ADCY7—hematologic cancer	2.18e-06	3.23e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOA3—hematologic cancer	2.18e-06	3.23e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CD—hematologic cancer	2.17e-06	3.22e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.17e-06	3.21e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GBA—hematologic cancer	2.17e-06	3.21e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NUP214—hematologic cancer	2.17e-06	3.21e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ALB—hematologic cancer	2.15e-06	3.18e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.14e-06	3.18e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ABCB1—hematologic cancer	2.13e-06	3.16e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—UGT1A1—hematologic cancer	2.13e-06	3.16e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCG2—hematologic cancer	2.12e-06	3.15e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTR—hematologic cancer	2.12e-06	3.15e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.09e-06	3.1e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO2—hematologic cancer	2.08e-06	3.08e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC22A1—hematologic cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CRABP1—hematologic cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NCOR1—hematologic cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GSTM1—hematologic cancer	2.07e-06	3.07e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	2.05e-06	3.04e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALOX5—hematologic cancer	2.02e-06	3e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.02e-06	3e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTT1—hematologic cancer	2.02e-06	2.99e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.99e-06	2.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTAP—hematologic cancer	1.98e-06	2.94e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—MTHFR—hematologic cancer	1.98e-06	2.93e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SDC1—hematologic cancer	1.97e-06	2.92e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NUP98—hematologic cancer	1.96e-06	2.9e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NQO1—hematologic cancer	1.94e-06	2.87e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CD44—hematologic cancer	1.94e-06	2.87e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ADCY7—hematologic cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOA3—hematologic cancer	1.9e-06	2.82e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	1.89e-06	2.81e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NUP214—hematologic cancer	1.89e-06	2.8e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.88e-06	2.79e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.86e-06	2.76e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTR—hematologic cancer	1.85e-06	2.74e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ABCG2—hematologic cancer	1.85e-06	2.74e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYCS—hematologic cancer	1.83e-06	2.72e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—MTHFR—hematologic cancer	1.83e-06	2.71e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	1.82e-06	2.7e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO2—hematologic cancer	1.81e-06	2.69e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.78e-06	2.64e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—FHL2—hematologic cancer	1.77e-06	2.62e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTT1—hematologic cancer	1.76e-06	2.61e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.74e-06	2.58e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AGRN—hematologic cancer	1.73e-06	2.57e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SDC1—hematologic cancer	1.72e-06	2.55e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.71e-06	2.53e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CD44—hematologic cancer	1.68e-06	2.49e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NQO1—hematologic cancer	1.68e-06	2.49e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	1.66e-06	2.46e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.65e-06	2.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HMMR—hematologic cancer	1.64e-06	2.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—IDH2—hematologic cancer	1.64e-06	2.44e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.64e-06	2.43e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—hematologic cancer	1.64e-06	2.43e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.62e-06	2.39e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYCS—hematologic cancer	1.59e-06	2.35e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	1.58e-06	2.34e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—EP300—hematologic cancer	1.56e-06	2.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.55e-06	2.29e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	1.54e-06	2.28e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CREBBP—hematologic cancer	1.54e-06	2.28e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.54e-06	2.28e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.53e-06	2.27e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ACP5—hematologic cancer	1.5e-06	2.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CA9—hematologic cancer	1.5e-06	2.23e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.48e-06	2.2e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.48e-06	2.2e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.48e-06	2.2e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CD44—hematologic cancer	1.46e-06	2.17e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NQO1—hematologic cancer	1.46e-06	2.17e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	1.46e-06	2.16e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ALB—hematologic cancer	1.44e-06	2.14e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CREBBP—hematologic cancer	1.43e-06	2.11e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.42e-06	2.1e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—IDH1—hematologic cancer	1.41e-06	2.09e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTP1—hematologic cancer	1.4e-06	2.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.4e-06	2.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.4e-06	2.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TXN—hematologic cancer	1.4e-06	2.07e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYCS—hematologic cancer	1.38e-06	2.05e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	1.38e-06	2.04e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HSP90AA1—hematologic cancer	1.37e-06	2.04e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.37e-06	2.03e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.35e-06	2.01e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.35e-06	2e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ALB—hematologic cancer	1.34e-06	1.98e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—hematologic cancer	1.32e-06	1.96e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.31e-06	1.95e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.31e-06	1.94e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GSTM1—hematologic cancer	1.29e-06	1.91e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NCOR1—hematologic cancer	1.29e-06	1.91e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.28e-06	1.89e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.27e-06	1.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.25e-06	1.85e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTP1—hematologic cancer	1.22e-06	1.81e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NUP98—hematologic cancer	1.21e-06	1.79e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.18e-06	1.75e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.17e-06	1.74e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NUP214—hematologic cancer	1.16e-06	1.72e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	1.16e-06	1.71e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTR—hematologic cancer	1.14e-06	1.69e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.14e-06	1.69e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MTHFR—hematologic cancer	1.14e-06	1.68e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NCOR1—hematologic cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GSTM1—hematologic cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO2—hematologic cancer	1.12e-06	1.66e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.1e-06	1.63e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.1e-06	1.63e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.08e-06	1.61e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SDC1—hematologic cancer	1.06e-06	1.57e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—EP300—hematologic cancer	1.05e-06	1.56e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CREBBP—hematologic cancer	1.02e-06	1.51e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—hematologic cancer	1.02e-06	1.51e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1e-06	1.48e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MTHFR—hematologic cancer	9.9e-07	1.47e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—EP300—hematologic cancer	9.71e-07	1.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CD—hematologic cancer	9.69e-07	1.44e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ALB—hematologic cancer	9.57e-07	1.42e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CG—hematologic cancer	9.55e-07	1.42e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—hematologic cancer	9.44e-07	1.4e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3R1—hematologic cancer	9.15e-07	1.36e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CD44—hematologic cancer	9e-07	1.33e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NQO1—hematologic cancer	9e-07	1.33e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CREBBP—hematologic cancer	8.85e-07	1.31e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYCS—hematologic cancer	8.52e-07	1.26e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.47e-07	1.25e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CB—hematologic cancer	8.45e-07	1.25e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CD—hematologic cancer	8.39e-07	1.24e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CG—hematologic cancer	8.32e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ALB—hematologic cancer	8.29e-07	1.23e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3R1—hematologic cancer	7.93e-07	1.17e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	7.76e-07	1.15e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CREBBP—hematologic cancer	7.71e-07	1.14e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.51e-07	1.11e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CB—hematologic cancer	7.32e-07	1.08e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CD—hematologic cancer	7.31e-07	1.08e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—hematologic cancer	7.3e-07	1.08e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ALB—hematologic cancer	7.22e-07	1.07e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PIK3CA—hematologic cancer	7.19e-07	1.07e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—hematologic cancer	7.11e-07	1.05e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—EP300—hematologic cancer	6.96e-07	1.03e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3R1—hematologic cancer	6.9e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GSTM1—hematologic cancer	6.9e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NCOR1—hematologic cancer	6.9e-07	1.02e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CB—hematologic cancer	6.37e-07	9.45e-06	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—hematologic cancer	6.34e-07	9.4e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—hematologic cancer	6.32e-07	9.37e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MTHFR—hematologic cancer	6.1e-07	9.04e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—EP300—hematologic cancer	6.03e-07	8.94e-06	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—hematologic cancer	5.87e-07	8.7e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—hematologic cancer	5.51e-07	8.16e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—EP300—hematologic cancer	5.25e-07	7.78e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PIK3CA—hematologic cancer	5.15e-07	7.63e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.12e-07	7.6e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.75e-07	7.04e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.51e-07	6.68e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PIK3CA—hematologic cancer	4.46e-07	6.61e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ALB—hematologic cancer	4.45e-07	6.59e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.25e-07	6.31e-06	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—hematologic cancer	4.21e-07	6.23e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.93e-07	5.82e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PIK3CA—hematologic cancer	3.89e-07	5.76e-06	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—hematologic cancer	3.64e-07	5.4e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—hematologic cancer	3.39e-07	5.03e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—EP300—hematologic cancer	3.24e-07	4.8e-06	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—hematologic cancer	3.17e-07	4.7e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.39e-07	3.55e-06	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—hematologic cancer	1.96e-07	2.9e-06	CbGpPWpGaD
